RACHEL WALCZYK: Open Payments
NPI 1699181693 · EAGAN, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 38 payments from 9 companies in 2025. Trend: 2023 $302 · 2024 $468 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $168 |
| Novo Nordisk Inc | 7 | $162 |
| GlaxoSmithKline, LLC. | 11 | $147 |
| Lilly USA, LLC | 5 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Lundbeck LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: FARXIGA, TRELEGY ELLIPTA, Ozempic, JARDIANCE, CAPLYTA, REXULTI, Rybelsus, Wegovy.
Industry payments across MN — which companies pay providers there.
